Study finds real-world outcomes with implantable cardioverter-defibrillators comparable to results in clinical trials

被引：0
作者：
Rishton, Louise
机构：
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2013年 / 11卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
[31]   Reuse of Explanted, Resterilized Implantable Cardioverter-Defibrillators A Cohort Study [J].
Pavri, Behzad B. ;
Lokhandwala, Yash ;
Kulkarni, Gaurav V. ;
Shah, Mandar ;
Kantharia, Bharat K. ;
Mascarenhas, Daniel A. N. .
ANNALS OF INTERNAL MEDICINE, 2012, 157 (08) :542-+
[32]   Remote Monitoring of Implantable Cardioverter-Defibrillators A Systematic Review and Meta-Analysis of Clinical Outcomes [J].
Parthiban, Nirmalatiban ;
Esterman, Adrian ;
Mahajan, Rajiv ;
Twomey, Darragh J. ;
Pathak, Rajeev K. ;
Lau, Dennis H. ;
Roberts-Thomson, Kurt C. ;
Young, Glenn D. ;
Sanders, Prashanthan ;
Ganesan, Anand N. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (24) :2591-2600
[33]   Clinical results with electrophysiologist-implanted cardioverter-defibrillators [J].
Singer, I ;
Deam, G ;
Payne, V ;
Cicic, A ;
Martin, T .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (01) :189-193
[34]   Long-Term Clinical Outcomes in Young Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators [J].
Burrows, Austin ;
Madias, Christopher ;
Rowin, Ethan J. ;
Maron, Martin S. ;
Maron, Barry J. .
CIRCULATION, 2019, 140
[35]   Is the clinical benefit of implantable cardioverter-defibrillators in heart failure patients declining? [J].
Spartalis, Michael ;
Iliopoulos, Dimitrios C. ;
Spartalis, Eleftherios ;
Athanasiou, Antonios ;
Paschou, Stavroula A. ;
Voudris, Vassilis ;
Siasos, Gerasimos .
JOURNAL OF CARDIOLOGY, 2020, 75 (05) :583-584
[36]   Possible benefits of dual-chamber implantable cardioverter-defibrillators in reducing inadequate therapy compared to conventional single-chamber implantable cardioverter-defibrillators: a clinical randomised study [J].
Deisenhofer, I ;
Kolb, C ;
Schreieck, J ;
Karch, MR ;
Zrenner, B ;
Schmitt, C .
EUROPEAN HEART JOURNAL, 2000, 21 :470-470
[37]   Clinical experience with 3rd generation implantable cardioverter-defibrillators [J].
Grimm, W ;
Menz, V ;
Hoffmann, J ;
Duangfung, T ;
Timmann, U ;
Funck, R ;
Waldhans, S ;
Moosdorf, R ;
Maisch, B .
HERZ KREISLAUF, 1998, 30 (06) :197-205
[38]   Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators [J].
Hakamata, Takahiro ;
Otsuki, Sou ;
Izumi, Daisuke ;
Sakaguchi, Yuta ;
Suzuki, Naomasa ;
Ikami, Yasuhiro ;
Hasegawa, Yuki ;
Yagihara, Nobue ;
Iijima, Kenichi ;
Chinushi, Masaomi ;
Fuse, Koichi ;
Inomata, Takayuki .
HEART RHYTHM, 2022, 19 (10) :1704-1711
[39]   Infections of implantable cardioverter-defibrillators:: frequency, predisposing factors and clinical significance [J].
Gil, P. ;
Guerrero, M. L. Fernandez ;
Bayona, J. F. ;
Rubio, J. M. ;
de Gorgolas, M. ;
Granizo, J. J. ;
Farre, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (06) :533-537
[40]   Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: what are the barriers to implementation in the 'real world'? [J].
Boriani, Giuseppe ;
Vitolo, Marco ;
Leyva, Francisco .
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (07) :1223-1226
12345